Navid J. Ayon

Bio

My name is Navid, and I am an analytical R&D scientist at the United States Pharmacopeia. My core technical expertise is in developing LC–MS-based analytical workflows for the analysis of exogenous molecules, including pharmaceuticals and biologics, and endogenous molecules, including biomarkers, to support disease diagnosis, drug discovery and development, and molecular characterization. My PhD training focused primarily on targeted LC-MS-based bioanalytical method development for quantitative small-molecule analysis. During my postdoctoral tenure, I received training in intact protein analysis using high-resolution mass spectrometers. I have been using chromatography and mass spectrometry to study what happens at the molecular level when a disease develops, when it's intervened upon by a 'drug' or 'drug-like' entity (what the drug does to the body), and what happens to those entities (what the body does to the drug). I firmly believe that progress ceases when curiosity wears out. There is no end to learning, and I feel fortunate to always find learning new things exciting. Onward and upward!